Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Association between chronic kidney disease and the cognitive function in subjects without overt dementia‚Ä©.

Ito H, Antoku S, Mori T, Nakagawa Y, Mizoguchi K, Matsumoto S, Omoto T, Shinozaki M, Nishio S, Abe M, Mifune M, Togane M.

Clin Nephrol. 2018 May;89(5):330-335. doi: 10.5414/CN109188.

PMID:
29057735
2.

Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes.

Ito H, Yamashita H, Nakashima M, Takaki A, Yukawa C, Matsumoto S, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Togane M.

J Clin Med Res. 2017 Apr;9(4):366-373. doi: 10.14740/jocmr2934w. Epub 2017 Feb 21.

3.

Comparison of the Renoprotective Effect of Febuxostat for the Treatment of Hyperuricemia between Patients with and without Type 2 Diabetes Mellitus: A Retrospective Observational Study.

Ito H, Antoku S, Abe M, Omoto T, Shinozaki M, Nishio S, Mifune M, Togane M, Nakata M, Yamashita T.

Intern Med. 2016;55(22):3247-3256. Epub 2016 Nov 15.

4.

Secular Trends in the Clinical Characteristics of Type 2 Diabetic Patients With Severe Hypoglycemia Between 2008 and 2013.

Ito H, Tsugami E, Ando S, Imai A, Matsumoto S, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Togane M.

J Clin Med Res. 2016 Oct;8(10):710-4. doi: 10.14740/jocmr2610w. Epub 2016 Aug 30.

5.

Relationships between the duration of illness and the current status of diabetes in elderly patients with type 2 diabetes mellitus.

Ito H, Omoto T, Abe M, Matsumoto S, Shinozaki M, Nishio S, Antoku S, Mifune M, Togane M.

Geriatr Gerontol Int. 2017 Jan;17(1):24-30. doi: 10.1111/ggi.12654. Epub 2015 Dec 4.

PMID:
26634299
6.

Flow Mediated Dilatation Is Reduced with the Progressive Stages of Glomerular Filtration Rate and Albuminuria in Type 2 Diabetic Patients without Coronary Heart Disease.

Ito H, Nakashima M, Meguro K, Furukawa H, Yamashita H, Takaki A, Yukawa C, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Togane M.

J Diabetes Res. 2015;2015:728127. doi: 10.1155/2015/728127. Epub 2015 Apr 29.

7.

Comparison of the antidiabetic effects of linagliptin among groups with a normal renal function and a mild or severe renal impairment - retrospective observation study of Japanese patients with type 2 diabetes mellitus.

Ito H, Abe M, Antoku S, Omoto T, Shinozaki M, Nishio S, Mifune M, Togane M.

Expert Opin Pharmacother. 2015 Feb;16(3):289-96. doi: 10.1517/14656566.2015.995091. Epub 2014 Dec 22.

PMID:
25529857
8.

Effects of switching from prandial premixed insulin therapy to basal plus two times bolus insulin therapy on glycemic control and quality of life in patients with type 2 diabetes mellitus.

Ito H, Abe M, Antoku S, Omoto T, Shinozaki M, Nishio S, Mifune M, Togane M.

Drug Des Devel Ther. 2014 Apr 23;8:391-6. doi: 10.2147/DDDT.S62709. eCollection 2014.

9.

The ratio of serum eicosapentaenoic acid to arachidonic acid is associated with renal impairment and diabetic macroangiopathies in elderly patients with type 2 diabetes.

Ito H, Ohira H, Chinen T, Omoto T, Shinozaki M, Nishio S, Abe M, Antoku S, Mifune M, Toagane M.

Diabetes Care. 2014;37(1):e7-8. doi: 10.2337/dc13-1306. No abstract available.

PMID:
24356609
10.

The Prevalence of the Risk Factors for Atherosclerosis among Type 2 Diabetic Patients Is Greater in the Progressive Stages of Chronic Kidney Disease.

Ito H, Antoku S, Furusho M, Shinozaki M, Abe M, Mifune M, Togane M, Ito K, Sanaka T.

Nephron Extra. 2013 Jul 12;3(1):66-72. doi: 10.1159/000353592. Print 2013 Jan.

11.

Vildagliptin is Effective for Glycemic Control in Diabetic Patients Undergoing either Hemodialysis or Peritoneal Dialysis.

Ito H, Mifune M, Matsuyama E, Furusho M, Omoto T, Shinozaki M, Nishio S, Antoku S, Abe M, Togane M, Koga S, Sanaka T.

Diabetes Ther. 2013 Dec;4(2):321-9. doi: 10.1007/s13300-013-0029-8. Epub 2013 Jun 26.

12.

Hypoglycemia observed during continuous glucose monitoring in patients with type 2 diabetes mellitus treated by subcutaneous insulin injection.

Ito H, Abe M, Shinozaki M, Oshikiri K, Yamashita H, Nakashima M, Takaki A, Yukawa C, Furusho M, Antoku S, Mifune M, Togane M.

Diabetes Technol Ther. 2013 Jul;15(7):586-90. doi: 10.1089/dia.2013.0034. Epub 2013 Apr 11.

PMID:
23578166
13.

[Photometric determination of Cu2+ ion using octabromo-tetrakis(4-methylpyridyl)porphine].

Mifune M, Iwado A, Kamino S, Enomoto S.

Yakugaku Zasshi. 2012;132(8):953-8. Japanese.

14.

Non-alcoholic fatty liver disease is an independent predictor for macroangiopathy in Japanese type 2 diabetic patients: a cross-sectional study.

Takeuchi Y, Ito H, Komatsu Y, Oshikiri K, Antoku S, Abe M, Mifune M, Togane M.

Intern Med. 2012;51(13):1667-75. Epub 2012 Jul 1.

15.

Hypertension resistant to antihypertensive agents commonly occurs with the progression of diabetic nephropathy in Japanese patients with type 2 diabetes mellitus: a prospective observational study.

Ito H, Mifune M, Abe M, Oshikiri K, Antoku S, Takeuchi Y, Togane M, Ando S, Tsugami E.

BMC Nephrol. 2012 Jun 27;13:48. doi: 10.1186/1471-2369-13-48.

16.

The usefulness of the revised classification for chronic kidney disease by the KDIGO for determining the frequency of diabetic micro- and macroangiopathies in Japanese patients with type 2 diabetes mellitus.

Ito H, Oshikiri K, Mifune M, Abe M, Antoku S, Takeuchi Y, Togane M, Yukawa C.

J Diabetes Complications. 2012 Jul-Aug;26(4):286-90. doi: 10.1016/j.jdiacomp.2012.04.011. Epub 2012 May 22.

PMID:
22621778
17.

Hyperuricemia is independently associated with coronary heart disease and renal dysfunction in patients with type 2 diabetes mellitus.

Ito H, Abe M, Mifune M, Oshikiri K, Antoku S, Takeuchi Y, Togane M.

PLoS One. 2011;6(11):e27817. doi: 10.1371/journal.pone.0027817. Epub 2011 Nov 18.

18.

[Photometric study on the reaction between 2,3,7,8,12,13,17,18-octabromo- 5,10,15,20-tetrakis-(4-methylpyridyl) porphine and various metal ions].

Mifune M, Iwado A, Taniguchi M, Kamino S, Enomoto S.

Yakugaku Zasshi. 2011;131(8):1233-40. Japanese.

19.

Mild anemia is frequent and associated with micro- and macroangiopathies in patients with type 2 diabetes mellitus.

Ito H, Takeuchi Y, Ishida H, Otawa A, Shibayama A, Antoku S, Abe M, Mifune M, Togane M.

J Diabetes Investig. 2010 Dec 3;1(6):273-8. doi: 10.1111/j.2040-1124.2010.00060.x.

20.

Long-term effect of metformin on blood glucose control in non-obese patients with type 2 diabetes mellitus.

Ito H, Ishida H, Takeuchi Y, Antoku S, Abe M, Mifune M, Togane M.

Nutr Metab (Lond). 2010 Nov 12;7:83. doi: 10.1186/1743-7075-7-83.

21.
22.
23.

High frequencies of diabetic micro- and macroangiopathies in patients with type 2 diabetes mellitus with decreased estimated glomerular filtration rate and normoalbuminuria.

Ito H, Takeuchi Y, Ishida H, Antoku S, Abe M, Mifune M, Togane M.

Nephrol Dial Transplant. 2010 Apr;25(4):1161-7. doi: 10.1093/ndt/gfp579. Epub 2009 Nov 5.

PMID:
19892756
24.

Effect of octabromination of a tetrakis(4-carboxyphenyl)porphine derivative bound to silica gels on HPLC retention behaviors of polyaromatic hydrocarbons.

Kitamura Y, Kawata K, Tanaka K, Furuyashiki Y, Mifune M, Tsukamoto I, Saito M, Haginaka J, Saito Y.

Talanta. 2006 Jul 15;69(5):1260-4. doi: 10.1016/j.talanta.2005.12.049. Epub 2006 Feb 10.

PMID:
18970712
25.

Peroxidase-like catalytic activity of Mn- and Fe-tetrakis(4-carboxyphenyl)porphines bound to aminopropyl-glass bead in oxidative reaction of heterocyclic amines.

Kitamura Y, Mifune M, Hino D, Yokotani S, Saito M, Tsukamoto I, Iwado A, Saito Y.

Talanta. 2006 Mar 15;69(1):43-7. doi: 10.1016/j.talanta.2005.08.045. Epub 2005 Sep 19.

PMID:
18970529
26.

pi-Electron interaction of PAHs with anion-exchange silica gels modified with anionic metal-porphine and -phthalocyanine derivatives as HPLC stationary phase for preparative column in organic solvents.

Mifune M, Minato K, Kitamura Y, Okazaki K, Iwado A, Akizawa H, Haginaka J, Motohashi N, Saito Y.

Talanta. 2004 Jul 8;63(4):1035-8. doi: 10.1016/j.talanta.2004.01.007.

PMID:
18969531
27.
28.
29.

Peroxidase-like catalytic activity of aqueous- and immobilized-Mn(3+)-octabromo-porphyrins on ion-exchange resin supplied as mimetic of horseradish peroxidase.

Kitamura Y, Mori K, Yamamoto M, Nozaki A, Saito M, Tsukamoto I, Mifune M, Saito Y.

Chem Pharm Bull (Tokyo). 2008 Sep;56(9):1364-6.

30.

Effect of carboxyl-group of D-glutamic acid or gamma-carboxy-D-glutamic acid as N-terminal amino acid of (111)in-diethylenetriaminepentaacetic acid-octreotide on accumulation of radioactivity in kidney.

Akizawa H, Saito M, Tsukamoto I, Ohkura T, Shimizu T, Kitamura Y, Mifune M, Saito Y, Arano Y, Saji H.

Biol Pharm Bull. 2007 Nov;30(11):2226-8.

31.

Catalytic activity of silica gels bound manganese(III)-porphyrin on oxidative reaction of adrenaline.

Kitamura Y, Takatsuki T, Kawamoto M, Saito M, Iwado A, Tsukamoto I, Mifune M, Saito Y.

Chem Pharm Bull (Tokyo). 2007 Mar;55(3):500-2.

32.

Peroxidase-like catalytic activity of Mn(3+)-octabromo-tetrakis(4-sulfophenyl)porphine on linoleate hydroperoxide and its analytical application.

Mifune M, Kamiguchi H, Tai TA, Kuremoto S, Yamamoto M, Tsukamoto I, Saito M, Kitamura Y, Saito Y.

Talanta. 2007 Jan 15;71(1):456-61. doi: 10.1016/j.talanta.2006.04.020. Epub 2006 May 19.

PMID:
19071327
33.

Evaluation of the state of active ingredients in pharmaceutical preparations using fourier transform-Raman difference spectra.

Mifune M, Iwasaki T, Kozaki Y, Tsukamoto I, Saito M, Kitamura Y, Yamaguchi T, Saito Y.

Yakugaku Zasshi. 2006 Dec;126(12):1363-7.

34.

Standard infrared absorption spectrum of betaine and optimal conditions for its measurement.

Kitamura Y, Iwasaki T, Saito M, Mifune M, Saito Y, Sato K, Yomota C, Tanamoto K.

Shokuhin Eiseigaku Zasshi. 2006 Oct;47(5):232-6.

35.

HPLC retention behaviors of pi-electron rich compounds on Ni2+- and Cu2+-phthalocyanine derivatives bound to silica gels in polar eluents.

Tsukamoto I, Saito M, Yamane M, Kawata K, Kitamura Y, Kitamura Y, Mifune M, Saito Y, Haginaka J.

Anal Sci. 2006 Jul;22(7):1035-8.

36.

Release of vesicular Zn2+ in a rat transient middle cerebral artery occlusion model.

Kitamura Y, Iida Y, Abe J, Mifune M, Kasuya F, Ohta M, Igarashi K, Saito Y, Saji H.

Brain Res Bull. 2006 May 31;69(6):622-5. Epub 2006 Mar 29.

PMID:
16716828
37.

In vivo measurement of presynaptic Zn2+ release during forebrain ischemia in rats.

Kitamura Y, Iida Y, Abe J, Mifune M, Kasuya F, Ohta M, Igarashi K, Saito Y, Saji H.

Biol Pharm Bull. 2006 Apr;29(4):821-3.

38.

Protective effect of zinc against ischemic neuronal injury in a middle cerebral artery occlusion model.

Kitamura Y, Iida Y, Abe J, Ueda M, Mifune M, Kasuya F, Ohta M, Igarashi K, Saito Y, Saji H.

J Pharmacol Sci. 2006 Feb;100(2):142-8. Epub 2006 Feb 11.

39.

HPLC retention behaviors of poly-aromatic-hydrocarbones on Cu(II)-octabromotetrakis(4-carboxyphenyl)porphine derivatives-immobilized aminopropyl silica gels in polar and non-polar eluents.

Mifune M, Kawata K, Tanaka K, Kitamura Y, Tsukamoto I, Saito M, Haginaka J, Saito Y.

Chem Pharm Bull (Tokyo). 2006 Jan;54(1):94-8.

40.

Peroxidase-like catalytic activity of anion-exchange resins modified with metal-porphyrins in oxidative reaction of hetrocyclic amines with hydrogen peroxide.

Mifune M, Hino D, Sugita H, Iwado A, Kitamura Y, Motohashi N, Tsukamoto I, Saito Y.

Chem Pharm Bull (Tokyo). 2005 Aug;53(8):1006-10.

41.

Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.

Ohtsu H, Mifune M, Frank GD, Saito S, Inagami T, Kim-Mitsuyama S, Takuwa Y, Sasaki T, Rothstein JD, Suzuki H, Nakashima H, Woolfolk EA, Motley ED, Eguchi S.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1831-6. Epub 2005 Jun 30.

PMID:
15994438
42.

G protein coupling and second messenger generation are indispensable for metalloprotease-dependent, heparin-binding epidermal growth factor shedding through angiotensin II type-1 receptor.

Mifune M, Ohtsu H, Suzuki H, Nakashima H, Brailoiu E, Dun NJ, Frank GD, Inagami T, Higashiyama S, Thomas WG, Eckhart AD, Dempsey PJ, Eguchi S.

J Biol Chem. 2005 Jul 15;280(28):26592-9. Epub 2005 May 19.

43.

Quantitative determination method for trace amount of penicillin contaminants in commercially available drug product by HPLC coupled with tandem mass spectrometry.

Takada W, Adachi T, Kihara N, Kitamura S, Kitagawa T, Mifune M, Saito Y.

Chem Pharm Bull (Tokyo). 2005 Feb;53(2):172-6.

44.
45.

Coloration of phenothiazines with metal-containing drugs.

Hosomi K, Okuno A, Umetani Y, Araya T, Matsuyama K, Haginaka J, Mifune M, Saito Y.

Yakugaku Zasshi. 2004 Sep;124(9):587-98.

46.

Signal transduction of betacellulin in growth and migration of vascular smooth muscle cells.

Mifune M, Ohtsu H, Suzuki H, Frank GD, Inagami T, Utsunomiya H, Dempsey PJ, Eguchi S.

Am J Physiol Cell Physiol. 2004 Sep;287(3):C807-13. Epub 2004 May 26.

47.

Effect of carboxylation of N-terminal phenylalanine of (111)in-DTPA (diethylenetriaminepentaacetic acid)-octreotide on accumulation of radioactivity in kidney.

Akizawa H, Takimoto H, Saito M, Iwado A, Mifune M, Saito Y, Uehara T, Arano Y, Mukai T, Hanaoka H, Saji H.

Biol Pharm Bull. 2004 Feb;27(2):271-2.

48.

HPLC retention behavior of poly-aromatic-hydrocarbons on aminopropyl silica gels modified with Cu(II)- and Ni(II)-phthalocyanine derivatives in non-polar eluent.

Akizawa H, Kitamura Y, Yamane M, Iwado A, Oda J, Mifune M, Motohashi N, Haginaka J, Saito Y.

Chem Pharm Bull (Tokyo). 2004 Jan;52(1):41-6.

49.

Metalloprotease-dependent ErbB ligand shedding in mediating EGFR transactivation and vascular remodelling.

Eguchi S, Frank GD, Mifune M, Inagami T.

Biochem Soc Trans. 2003 Dec;31(Pt 6):1198-202. Review.

PMID:
14641025
50.

Hepatocyte growth factor regulates proteoglycan synthesis in interstitial fibroblasts.

Kobayashi E, Sasamura H, Mifune M, Shimizu-Hirota R, Kuroda M, Hayashi M, Saruta T.

Kidney Int. 2003 Oct;64(4):1179-88.

Supplemental Content

Loading ...
Support Center